Agile Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and welcome to the 40th Annual JPMorgan Healthcare Conference. My name is Sushil Bhandaru, and I'm an analyst in JPMorgan's health care group.
Before we begin today's session, we want to call attention to the blue question box at the bottom of your screen. (Operator Instructions)
With that, I'm pleased to introduce Al Altomari, Chairman and CEO of Agile Therapeutics, to tell you a bit more about their business.
Thanks, Sushil. So first of all, thank you for the introduction, and I'd also like to take a moment to thank JPMorgan, particularly Mike Gaito and the banking team, for giving us this opportunity to provide an update in what a really important time for Agile Therapeutics.
So just to remind everybody, Agile Therapeutics is a publicly traded company. And throughout my presentation, I will be making forward-looking statements. So I'd encourage you to take a look at all our most recent filings that are available either on our corporate
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
